|
PHC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.70560000146392E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.33230000049545E-08 |
| Normal-vs-Stage2 |
1.711550E-01 |
| Normal-vs-Stage3 |
6.434900E-04 |
| Normal-vs-Stage4 |
2.4256999999972E-05 |
| Stage1-vs-Stage2 |
2.913900E-02 |
| Stage1-vs-Stage3 |
2.328000E-01 |
| Stage1-vs-Stage4 |
6.003000E-01 |
| Stage2-vs-Stage3 |
2.292800E-01 |
| Stage2-vs-Stage4 |
3.190300E-02 |
| Stage3-vs-Stage4 |
1.731410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.70410000005705E-07 |
| Normal-vs-AfricanAmerican |
2.611100E-04 |
| Normal-vs-Asian |
6.908000E-02 |
| Caucasian-vs-AfricanAmerican |
1.887810E-01 |
| Caucasian-vs-Asian |
9.707200E-01 |
| AfricanAmerican-vs-Asian |
6.306200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.955750E-04 |
| Normal-vs-Female |
1.7835999344129E-10 |
| Male-vs-Female |
7.89290000000609E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.173580E-01 |
| Normal-vs-Age(41-60Yrs) |
4.28910000005445E-06 |
| Normal-vs-Age(61-80Yrs) |
2.40999999956415E-07 |
| Normal-vs-Age(81-100Yrs) |
6.743600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.177200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.902600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.252600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.954600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.370600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.841800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.783600E-04 |
| Normal-vs-Grade 2 |
4.0706000015156E-08 |
| Normal-vs-Grade 3 |
2.776200E-03 |
| Normal-vs-Grade 4 |
3.51600000003671E-06 |
| Grade 1-vs-Grade 2 |
1.312160E-02 |
| Grade 1-vs-Grade 3 |
5.359000E-04 |
| Grade 1-vs-Grade 4 |
3.710100E-02 |
| Grade 2-vs-Grade 3 |
7.601000E-03 |
| Grade 2-vs-Grade 4 |
5.564000E-01 |
| Grade 3-vs-Grade 4 |
1.171630E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.76449999745554E-08 |
| Normal-vs-ccB subtype |
1.449950E-02 |
| ccA subtype-vs-ccB subtype |
8.144300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.58155999999687E-05 |
| Normal-vs-N1 |
1.415880E-02 |
| N0-vs-N1 |
2.180400E-01 |
|
|
